Method for anchoring a mitral valve

Information

  • Patent Grant
  • 8672998
  • Patent Number
    8,672,998
  • Date Filed
    Monday, April 29, 2013
    11 years ago
  • Date Issued
    Tuesday, March 18, 2014
    10 years ago
Abstract
An artificial mitral valve is anchored in the left atrium by placing the valve between the annulus of the natural mitral valve and an artificial annulus. The artificial annulus is formed by inserting a tool into the coronary sinus, and adjusting the tool to force the wall of the left atrium to form an annulus above the artificial valve, this locking it in place and forming a hemostatic seal.
Description
BACKGROUND

1. Technical Field


The invention relates to minimally invasive cardiac surgery.


2. Description of the Related Art


The art of artificial heart valves is well known. Recently there is a strong interest in minimally invasive methods of replacing defective heart valves, and in particular in percutaneous deployment methods. In those procedures, the new valve is delivered and all the steps to install it, are performed via a fairly narrow catheter, typically 8-10 mm diameter.


Replacing major surgery with the small incision needed for inserting such a catheter is a major step in cardiac surgery.


The mitral valve is a particularly difficult case as the heart has an unfavorable geometry for anchoring a replacement valve. In conventional cardiac surgery the new valve is sutured to the tissue around the natural valve, which is surrounded by an annular ring of more rigid tissue known as the valve annulus. This procedure is not practical for percutaneous surgery. The main object of the invention is to devise an anchoring method for a replacement mitral valve. A further object is making the method both reversible and percutaneous.


BRIEF SUMMARY

An artificial mitral valve is anchored in the left atrium by placing the valve between the annulus of the natural mitral valve and an artificial annulus. The artificial annulus is formed by inserting a tool into the coronary sinus, and adjusting the tool to force the wall of the left atrium to form an annulus above the artificial valve, thus locking the artificial mitral valve in place and forming a hemostatic seal. The artificial mitral valve can be held by compression from above or by circumferential compression from the tool. The compression can be released in order to remove the artificial mitral valve, if desired.





BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS


FIG. 1 is a longitudinal cross section of the heart, showing the left and right atriums.



FIG. 2 is a longitudinal cross section of the heart as in FIG. 1, showing a deployed artificial mitral valve.



FIG. 3 is a longitudinal cross section of the heart as in FIG. 1, showing an artificial mitral valve anchored in place according to the invention.



FIG. 4 is a general view of the anchoring tool.



FIG. 5 is a schematic view showing the use of the anchoring tool in a percutaneous operation.



FIG. 6A is a partial isometric view of the anchoring tool.



FIG. 6B is a side elevational view of a portion of the anchoring tool.



FIG. 7 is a schematic view showing the use of the invention in anchoring a balloon expandable valve.





DETAILED DESCRIPTION

Referring now to FIG. 1, the cross section of the upper part of the heart shows the left atrium 1, the right atrium 2, pulmonary veins 3 and 4, tricuspid valve 5 and mitral valve 6, interventricular septum 7, atrioventricular septum 8, coronary sinus 10, interatrial septum 11, and tendon of Todaro 12. An artificial mitral valve 32 is introduced into the left atrium to replace a defective mitral valve 6. The artificial mitral valve 32 is of flexible construction in order to be deployed percutaneously via a catheter 38. For deployment the artificial mitral valve 32 is compressed into an elongated oval shape. The art of percutaneous deployment is well known in minimally invasive surgery. One way to deploy the artificial mitral valve 32 is to pass catheter 38 via septum 11, after entering the right atrium via the superior vena cava. An anchoring tool 9 is shown in FIG. 1 already inside the coronary sinus 10. The periphery of mitral valves 6 is less flexible and forms a shape 39 known as the mitral valve annulus.


Referring now to FIG. 2, the artificial mitral valve 32 is allowed to expand to its normal form. The artificial mitral valve 32 comprises of very flexible leaflets 34, and a less flexible annulus 33. The overall shape of the artificial mitral valve 32 is matched to the area above the mitral valve annulus, which is generally “D” shaped. The cross section of the annulus can be round, oval, rectangular or any other shape suitable for forming a hemostatic seal when seated above the annulus 39 of the defective mitral valve 6. Annulus 33 can also be composed of multiple materials, some more rigid to better control the shape and some more flexible to help if forming a hemostatic seal. For example, annulus 33 can be made of soft silicone rubber with a Nitinol wire ring embedded in the annulus to control the shape of the ring. The leaflets 34 can be made of silicone rubber, Dacron or any other thin flexible material which is compatible with the heart. Artificial mitral valves capable of being delivered via a catheter are commercially available from Edwards Life Sciences (www.edwards.com).


At this stage the anchoring tool 9 is in the coronary sinus but the anchoring tool 9 is left in the relaxed and flexible position, as explained later on.


After the artificial mitral valve 32 is placed at the final location above the defective valve 3, the artificial mitral valve 32 has to be anchored into place. The artificial mitral valve 32 is brought into the correct position by using the delivery catheter to push the artificial mitral valve 32 downwards (this is also aided by the downwards blood flow). To secure the artificial mitral valve 32 in place, a second annulus, similar to the natural annulus 39 of the mitral valve 6, is created above the artificial mitral valve 32 by a ring-like anchoring tool 9 shown in cross section in FIG. 3. When anchoring tool 9 is tightened it pulls in the outside wall of left atrium 1 as well as interatrial septum 11 to form an almost full ring 36 around the valve annulus 33. This locks the artificial mitral valve 32 between the natural annulus 39 of mitral valve 6 and an artificial annulus 36. By further tightening anchoring tool 9 a hemostatic seal is established. Since valve annulus 33 is flexible (as is anchoring tool 9) it will conform to the exact shape of the natural annulus 39. Inside the right atrium, tool 9 is placed against the interatrial septum 11 just above tendon of Todaro 12.


Details of anchoring tool 9 are shown in FIG. 4. Anchoring tool 9 is made of rigid links 25 connected by two flexible cables 26 and 27. Protrusions or barbs 28 can be added to increase anchoring in the coronary sinus. A barb 24 is mounted on end piece 23. This barb is covered by tube 21 of adjustment tool 15. When tube 21 is detached from end piece 23, barb 24 springs open and secures the position of anchoring tool 9 relative to septum 11 (shown in FIG. 1). The shape of anchoring tool 9 is adjusted by tensioning cable 26 by turning screw 22 using matching socket 21 connected to inner flexible tube 19. Both anchoring tool 9 and flexible tube 15 have a hole for guide wire 18. Flexible tube 19 can rotate freely inside flexible adjustment tool 15. Both adjustment tool 15 and inner flexible tube are made of metal bellows type hose or of a braided hose, as these type hoses are torsionally stiff but easy to bend. It is desirable to make screw 22 and socket 20 of a ferromagnetic material, and provide a small rare-earth magnet (not shown) inside socket 20. This facilitates locating screw 22 if adjustment tool 15 has to be re-connected to anchoring tool 9 inside the heart.


Referring now to FIG. 5 and FIG. 4, the percutaneous use of an embodiment of the invention is shown. Anchoring tool 9 is attached to flexible adjustment tool 15 and is inserted into the right atrium 2 via catheter 14, typically through the superior vena cava 13 over a guide wire 18. Guide wire 18 is inserted first, via ostium 37, all the way to the end of the coronary sinus 10. Tools 9 and 15 are guided by the wire 18. Anchoring tool 9 can be bent into shape by turning knob 17 while holding shaft 16. Turning knob 17 will turn socket 20 and tighten cable 26. To release adjustment tool 15, knob 17 is pressed into shaft 16 causing tool 9 to be ejected from tube 21 and embed barb 24 in septum 11. The operation is fully reversible as long as guide wire 18 is in place. It is even possible to re-adjust or remove anchoring tool 9 at a later date, if socket 20 can be lined up with screw 22. This is assisted by magnetic attraction, as explained earlier. The reversibility of the operation is a major advantage should the artificial mitral valve 32 need to be removed.


The same tool can be used both as an adjustment tool for controlling regurgitation in a natural mitral valve and as an anchoring tool for an artificial mitral valve. This is important as in many cases an adjustment can correct the problem in the natural mitral valve, without need for installing an artificial mitral valve. At a later date an artificial mitral valve may be required. In such a case, anchoring tool 9 simply needs to be loosened, an artificial mitral valve installed and anchoring tool 9 re-tightened.


A more detailed view of anchoring tool 9 is given in FIGS. 6A and 6B. Each one of links 25 are cut at an angle 31. Angles 31 and length of links 25 determine the final shape of anchoring tool 9 when cable 26 is fully tightened. In order to keep links 25 in a single plane, the ends are cut in a V-shape as shown in insert drawing 40, which depicts a side view of links 25. The V shaped cut can be aligned with the longitudinal axis, as shown in 40, or can form an arbitrary angle to it. In such a case anchoring tool 9 will acquire a three-dimensional shape when tightened rather than fit in a single plane. Tightening screw 22 pulls nut 30 and tensions cable 26, causing anchoring tool 9 to tighten towards the final shape. The cross section of links 25 is designed to allow maximal blood flow in the coronary sinus. Cable 26 is permanently attached to nut 30 and to the last link (not shown), which is the link furthest away from end piece 23. Cable 27 is permanently attached to the last link but not attached to end piece 23 in order to accommodate the change in length when anchoring tool 9 is changing from straight to curved. When cable 26 is loosened, anchoring tool 9 is very flexible, similar to a chain. When cable 26 is fully tight, anchoring tool 9 can exert considerable force (a few Kg) in the radial direction.


By the way of example, anchoring tool 9 is made of type 316 stainless steel, with links 25 having a cross section of about 2×3 mm, and a length of about 12 mm each. Each links has three holes about 1 mm diameter each. Cables 26 and 27 are made of stainless steel as well and have an outside diameter of about 0.8 mm. Screw 22 is made of 400 series stainless (to be magnetic) and is 2 mm diameter with 3 mm hex head.


The term “annulus” in this disclosure has to be broadly interpreted. It need not be a complete circle, as anchoring tool 9 encircles the majority of the artificial mitral valve circumference but not all of it, due to the presence of the aortic valve. The term “artificial annulus” should be understood as any arc-like retention feature formed by anchoring tool 9. Also, while the preferred embodiment shows the artificial annulus formed above the artificial mitral valve, it is obvious that the artificial annulus can be used to anchor the artificial mitral valve even without being above it. By the way of example, the periphery of the artificial mitral valve can have a groove and the artificial annulus can engage this groove. In a different embodiment the base of the artificial mitral valve can be wider than the top part, thus allowing anchoring by an artificial annulus. It is also clear that the anchoring tool 9 need not be made of individual links. The anchoring tool 9 can be made of an elastic material such as Nitinol and rely on the elastic force to form the artificial annulus. While the term “anchoring” in this disclosure implies forming a hemostatic seal between the artificial valve annulus and the existing mitral vale annulus, it is understood that the seal need not be perfect to practice the invention, as any small gaps tend to seal themselves over time due to formation of scar tissue and deposits. A further improvement can be in the form of adding magnets to the artificial valve annulus and adding ferromagnetic material to anchoring tool 9. This helps align the artificial mitral valve 32 with the artificial annulus. While the force of the magnets may be insufficient to retain the artificial mitral valve 32, it is sufficient to hold in the correct position until anchoring tool 9 is tightened.


An alternate way of using the artificial annulus is to use it as an anchoring base for a balloon expandable valve. Balloon expandable valves are well known in the art and are used, for example, as replacement aortic valves. Until now they were not used as mitral valves since there was no sufficiently rigid surface to expand the balloon against. FIG. 7 shows use of an anchoring tool 9 to form a rigid artificial annulus 36, then expansion of a balloon mounted valve 42, mounted on balloon 41, into the rigid structure that was formed.


The various embodiments described above can be combined to provide further embodiments. All of the commonly assigned US patent application publications, US patent applications, foreign patents, foreign patent applications and non-patent publications referred to in this specification and/or listed in the Application Data Sheet, including but not limited to U.S. application Ser. No. 11/475,978, filed Jun. 28, 2006 are incorporated herein by reference, in their entirety.

Claims
  • 1. A method for anchoring an artificial mitral valve in a left atrium of a heart, the method comprising: deploying the artificial mitral valve in the left atrium of the heart;positioning the artificial mitral valve above a natural annulus of a natural mitral valve in the heart; andshaping an atrial wall to form an artificial annulus to anchor artificial mitral valve.
  • 2. The method of claim 1 wherein shaping an atrial wall to form an artificial annulus includes shaping the atrial wall to form the artificial annulus at least one of above or around the artificial mitral valve.
  • 3. The method of claim 1, further comprising: percutaneously deploying the artificial mitral valve in the left atrium.
  • 4. The method of claim 1 further comprising: inserting a tool in the coronary sinus to at least partially form the artificial annulus.
  • 5. The method of claim 1 wherein deploying the artificial mitral valve includes expanding a balloon.
  • 6. The method of claim 1, further comprising: permanently installing a tool in the coronary sinus to at least partially form the artificial annulus.
  • 7. A method to replicate a function of a natural mitral valve in a left atrium of a heart, the natural mitral valve about which a coronary sinus of the heart at least partially extends, the method comprising: inserting an artificial mitral valve inside an opening formed by the natural mitral valve in the left atrium of the heart;inserting an elongate member in a flexible state at least partially into the coronary sinus while in the flexible state such that the elongate member at least partially encircles a portion of the artificial mitral valve; andwhile the elongate member is at least partially in the coronary sinus, transitioning the elongate member from the flexible state to a more rigid state in which the elongate member forms an artificial annulus to physically secure the artificial mitral valve in the opening.
  • 8. The method of claim 7, further comprising: adjusting the elongate member during the installation in the heart; andremoving the elongated member from the coronary sinus at a later date.
  • 9. The method of claim 7 wherein the elongate member comprises a plurality of rigid links and a cable that connects the rigid links, and transitioning the elongate member from the flexible state to a more rigid state includes tensioning of the cable.
  • 10. The method of claim 7, further comprising: percutaneously delivering the elongate member to the left atrium of the heart via a detachable adjustment tool.
  • 11. The method of claim 7, further comprising: delivering the elongate member via a catheter using an adjustment tool, and detaching the elongate member from the adjustment tool to expose at least one elastic barb on the elongate member.
  • 12. The method of claim 7, further comprising: delivering the elongate member via a catheter using an adjustment tool to which the elongate member is detachably magnetically coupled.
  • 13. The method of claim 7, further comprising: securing the artificial mitral valve without sutures between said artificial annulus and the heart.
  • 14. A method to replicate a function of a natural mitral valve in a left atrium of a heart, a coronary sinus of the heart forming a path extending at least partially about the natural mitral valve, the method comprising: percutaneously inserting an artificial mitral valve inside an opening formed by the natural mitral valve of the heart;percutaneously inserting an elongate member in a flexible state in the coronary sinus; andpercutaneously adjusting a dimension of the elongate member to form an artificial annulus in the coronary sinus to physically secure the artificial mitral valve in the opening without any sutures between the artificial mitral valve and the heart.
  • 15. The method of claim 14, further comprising: delivering the artificial mitral valve and the elongate member via a catheter.
  • 16. The method of claim 14 wherein the elongate member comprises a plurality of rigid links and a cable that connects the rigid links, and percutaneously adjusting a dimension of the elongate member includes tensioning the cable.
  • 17. The method of claim 14 wherein percutaneously adjusting a dimension of the elongate member includes tensioning the elongate member into the more rigid state to apply a radially inward force to an annulus of the artificial mitral valve via the coronary sinus to secure the annulus of the artificial valve between a natural annulus of the natural mitral valve and the artificial annulus formed by the elongate member.
  • 18. The method of claim 14 wherein percutaneously adjusting a dimension of the elongate member includes moving a tension adjustment coupler in one direction to increase a tension in the elongate member or moving the tension adjustment coupler in another direction to decrease the tension in the elongate member.
  • 19. The method of claim 18 wherein the tension adjustment coupler is part of a magnetic coupler assembly, and further comprising: magnetically mating the magnetic coupler assembly with a portion of an adjustment tool which portion is at least partially percutaneously receivable in the heart.
US Referenced Citations (282)
Number Name Date Kind
5021059 Kensey et al. Jun 1991 A
5047047 Yoon Sep 1991 A
5100418 Yoon et al. Mar 1992 A
5104399 Lazarus Apr 1992 A
5122137 Lennox Jun 1992 A
5156609 Nakao et al. Oct 1992 A
5192314 Daskalakis Mar 1993 A
5242456 Nash et al. Sep 1993 A
5258000 Glanturco Nov 1993 A
5312435 Nash et al. May 1994 A
5320632 Heidmueller Jun 1994 A
5364408 Gordon Nov 1994 A
5366443 Eggers et al. Nov 1994 A
5366459 Yoon Nov 1994 A
5368601 Sauer et al. Nov 1994 A
5374275 Bradley et al. Dec 1994 A
5450860 O'Connor Sep 1995 A
5478353 Yoon Dec 1995 A
5507811 Koike et al. Apr 1996 A
5531760 Alwafaie Jul 1996 A
5593424 Northrup, III Jan 1997 A
5713896 Nardella Feb 1998 A
5716397 Myers Feb 1998 A
5720726 Marcadis et al. Feb 1998 A
5728114 Evans et al. Mar 1998 A
5752965 Francis et al. May 1998 A
5782861 Cragg et al. Jul 1998 A
5800495 Machek et al. Sep 1998 A
5824066 Gross Oct 1998 A
5836990 Li Nov 1998 A
5865791 Whayne et al. Feb 1999 A
5919207 Taheri Jul 1999 A
5961440 Schweich, Jr. et al. Oct 1999 A
5964782 Lafontaine et al. Oct 1999 A
5971994 Fritzsch Oct 1999 A
5984950 Cragg et al. Nov 1999 A
6001069 Tachibana et al. Dec 1999 A
6024096 Buckberg Feb 2000 A
6074417 Peredo Jun 2000 A
6074418 Buchanan et al. Jun 2000 A
6104944 Martinelli Aug 2000 A
6113610 Poncet Sep 2000 A
6132438 Fleischman et al. Oct 2000 A
6203554 Roberts Mar 2001 B1
6210432 Solem et al. Apr 2001 B1
6221103 Melvin Apr 2001 B1
6221104 Buckberg et al. Apr 2001 B1
6241747 Ruff Jun 2001 B1
6248124 Pedros et al. Jun 2001 B1
6258258 Sartori et al. Jul 2001 B1
6287321 Jang Sep 2001 B1
6304769 Arenson et al. Oct 2001 B1
6306135 Ellman et al. Oct 2001 B1
6332864 Schweich, Jr. et al. Dec 2001 B1
6346105 Tu et al. Feb 2002 B1
6358258 Arcia et al. Mar 2002 B1
6358277 Duran Mar 2002 B1
6360749 Jayaraman Mar 2002 B1
6379366 Fleischman et al. Apr 2002 B1
6391048 Ginn et al. May 2002 B1
6391054 Carpentier et al. May 2002 B2
6402680 Mortier et al. Jun 2002 B2
6402781 Langberg et al. Jun 2002 B1
6406420 McCarthy et al. Jun 2002 B1
6409760 Melvin Jun 2002 B1
6416459 Haindl Jul 2002 B1
6436052 Nikolic et al. Aug 2002 B1
6450171 Buckberg et al. Sep 2002 B1
6475223 Werp et al. Nov 2002 B1
6485489 Teirstein et al. Nov 2002 B2
6506210 Kanner Jan 2003 B1
6537198 Vidlund et al. Mar 2003 B1
6537314 Langberg et al. Mar 2003 B2
6540670 Hirata et al. Apr 2003 B1
6551312 Zhang et al. Apr 2003 B2
6569160 Goldin et al. May 2003 B1
6569198 Wilson et al. May 2003 B1
6575971 Hauck et al. Jun 2003 B2
6589208 Ewers et al. Jul 2003 B2
6626930 Allen et al. Sep 2003 B1
6632238 Ginn et al. Oct 2003 B2
6662034 Segner et al. Dec 2003 B2
6676685 Pedros et al. Jan 2004 B2
6723038 Schroeder et al. Apr 2004 B1
6726704 Loshakove et al. Apr 2004 B1
6726716 Marquez Apr 2004 B2
6743241 Kerr Jun 2004 B2
6749622 McGuckin et al. Jun 2004 B2
6760616 Hoey et al. Jul 2004 B2
6780197 Roe et al. Aug 2004 B2
6797001 Mathis et al. Sep 2004 B2
6800090 Alferness et al. Oct 2004 B2
6824562 Mathis et al. Nov 2004 B2
6840957 DiMatteo et al. Jan 2005 B2
6852076 Nikolic et al. Feb 2005 B2
6855143 Davison et al. Feb 2005 B2
6890353 Cohn et al. May 2005 B2
6899674 Viebach et al. May 2005 B2
6908478 Alferness et al. Jun 2005 B2
6949122 Adams et al. Sep 2005 B2
6960229 Mathis et al. Nov 2005 B2
6986775 Morales et al. Jan 2006 B2
6989028 Lashinski et al. Jan 2006 B2
6991649 Sievers Jan 2006 B2
6994093 Murphy et al. Feb 2006 B2
6997951 Solem et al. Feb 2006 B2
7025776 Houser et al. Apr 2006 B1
7050848 Hoey et al. May 2006 B2
7052487 Cohn et al. May 2006 B2
7101395 Tremulis et al. Sep 2006 B2
7144363 Pai et al. Dec 2006 B2
7160322 Gabbay Jan 2007 B2
7166127 Spence et al. Jan 2007 B2
7177677 Kaula et al. Feb 2007 B2
7186210 Feld et al. Mar 2007 B2
7189202 Lau et al. Mar 2007 B2
7279007 Nikolic et al. Oct 2007 B2
7300435 Wham et al. Nov 2007 B2
7303526 Sharkey et al. Dec 2007 B2
7374530 Schaller May 2008 B2
7399271 Khairkhahan et al. Jul 2008 B2
7431726 Spence et al. Oct 2008 B2
7452325 Schaller Nov 2008 B2
7507252 Lashinski et al. Mar 2009 B2
7582051 Khairkhahan et al. Sep 2009 B2
7611534 Kapadia et al. Nov 2009 B2
7704277 Zakay et al. Apr 2010 B2
7736388 Goldfarb et al. Jun 2010 B2
7749249 Gelbart et al. Jul 2010 B2
8128644 Carley et al. Mar 2012 B2
20010003158 Kensey et al. Jun 2001 A1
20010005787 Oz et al. Jun 2001 A1
20010018611 Solem et al. Aug 2001 A1
20010020126 Swanson et al. Sep 2001 A1
20010041915 Roue et al. Nov 2001 A1
20010044568 Langberg et al. Nov 2001 A1
20020013621 Stobie et al. Jan 2002 A1
20020016628 Langberg Feb 2002 A1
20020026092 Buckberg et al. Feb 2002 A1
20020055775 Carpentier et al. May 2002 A1
20020082621 Schurr et al. Jun 2002 A1
20020087173 Alferness et al. Jul 2002 A1
20020111647 Khairkhahan et al. Aug 2002 A1
20020115944 Mendes et al. Aug 2002 A1
20020161394 Macoviak et al. Oct 2002 A1
20020169359 McCarthy et al. Nov 2002 A1
20020169360 Taylor et al. Nov 2002 A1
20020169504 Alferness et al. Nov 2002 A1
20020183836 Liddicoat et al. Dec 2002 A1
20020183841 Cohn et al. Dec 2002 A1
20020188170 Santamore et al. Dec 2002 A1
20020198603 Buckberg et al. Dec 2002 A1
20030045896 Murphy et al. Mar 2003 A1
20030050682 Sharkey et al. Mar 2003 A1
20030050685 Nikolic et al. Mar 2003 A1
20030050693 Quijano et al. Mar 2003 A1
20030069570 Witzel et al. Apr 2003 A1
20030069593 Tremulis et al. Apr 2003 A1
20030069636 Solem et al. Apr 2003 A1
20030078465 Pai et al. Apr 2003 A1
20030078652 Sutherland Apr 2003 A1
20030078671 Lesniak et al. Apr 2003 A1
20030083742 Spence et al. May 2003 A1
20030105384 Sharkey et al. Jun 2003 A1
20030105520 Alferness et al. Jun 2003 A1
20030109770 Sharkey et al. Jun 2003 A1
20030149333 Alferness Aug 2003 A1
20030163191 Nikolic et al. Aug 2003 A1
20030167055 Kolata et al. Sep 2003 A1
20030220667 Van der Burg et al. Nov 2003 A1
20030229395 Cox Dec 2003 A1
20040002626 Feld et al. Jan 2004 A1
20040054279 Hanley Mar 2004 A1
20040127916 Bolduc et al. Jul 2004 A1
20040133220 Lashinski et al. Jul 2004 A1
20040133273 Cox Jul 2004 A1
20040138529 Wiltshire et al. Jul 2004 A1
20040138744 Lashinski et al. Jul 2004 A1
20040138745 Macoviak et al. Jul 2004 A1
20040153146 Lashinski et al. Aug 2004 A1
20040158321 Reuter et al. Aug 2004 A1
20040186566 Hindrichs et al. Sep 2004 A1
20040215232 Belhe et al. Oct 2004 A1
20040243170 Suresh et al. Dec 2004 A1
20040249408 Murphy et al. Dec 2004 A1
20040249453 Cartledge et al. Dec 2004 A1
20040260390 Sarac et al. Dec 2004 A1
20040260393 Rahdert et al. Dec 2004 A1
20040267191 Gifford, III et al. Dec 2004 A1
20040267358 Reitan Dec 2004 A1
20050004668 Aklog et al. Jan 2005 A1
20050015109 Lichtenstein Jan 2005 A1
20050038509 Ashe Feb 2005 A1
20050054938 Wehman et al. Mar 2005 A1
20050055089 Macoviak et al. Mar 2005 A1
20050060030 Lashinski et al. Mar 2005 A1
20050064665 Han Mar 2005 A1
20050075727 Wheatley Apr 2005 A1
20050080402 Santamore et al. Apr 2005 A1
20050096498 Houser et al. May 2005 A1
20050096647 Steinke et al. May 2005 A1
20050107723 Wehman et al. May 2005 A1
20050107871 Realyvasquez et al. May 2005 A1
20050125030 Forsberg et al. Jun 2005 A1
20050131441 Iio et al. Jun 2005 A1
20050137689 Salahieh et al. Jun 2005 A1
20050137700 Spence et al. Jun 2005 A1
20050143809 Salahieh et al. Jun 2005 A1
20050149014 Hauck et al. Jul 2005 A1
20050154252 Sharkey et al. Jul 2005 A1
20050177180 Kaganov et al. Aug 2005 A1
20050177227 Heim et al. Aug 2005 A1
20050182365 Hennemann et al. Aug 2005 A1
20050187620 Pai et al. Aug 2005 A1
20050197692 Pai et al. Sep 2005 A1
20050197693 Pai et al. Sep 2005 A1
20050197694 Pai et al. Sep 2005 A1
20050197716 Sharkey et al. Sep 2005 A1
20050209636 Widomski et al. Sep 2005 A1
20050216052 Mazzocchi et al. Sep 2005 A1
20050216054 Widomski et al. Sep 2005 A1
20050240249 Tu et al. Oct 2005 A1
20050251116 Steinke et al. Nov 2005 A1
20050267573 Macoviak et al. Dec 2005 A9
20050267574 Cohn et al. Dec 2005 A1
20050273138 To et al. Dec 2005 A1
20060014998 Sharkey et al. Jan 2006 A1
20060015002 Moaddeb et al. Jan 2006 A1
20060015003 Moaddes et al. Jan 2006 A1
20060015038 Weymarn-Scharli Jan 2006 A1
20060025800 Suresh Feb 2006 A1
20060030881 Sharkey et al. Feb 2006 A1
20060058871 Zakay et al. Mar 2006 A1
20060135968 Schaller Jun 2006 A1
20060135970 Schaller Jun 2006 A1
20060173536 Mathis et al. Aug 2006 A1
20060184242 Lichtenstein Aug 2006 A1
20060199995 Vijay Sep 2006 A1
20060229491 Sharkey et al. Oct 2006 A1
20060235286 Stone et al. Oct 2006 A1
20060241334 Dubi et al. Oct 2006 A1
20060241745 Solem Oct 2006 A1
20060264980 Khairkhahan et al. Nov 2006 A1
20060276683 Feld et al. Dec 2006 A1
20060281965 Khairkhahan et al. Dec 2006 A1
20060293698 Douk Dec 2006 A1
20070016068 Grunwald et al. Jan 2007 A1
20070027533 Douk Feb 2007 A1
20070118215 Moaddeb May 2007 A1
20070135826 Zaver et al. Jun 2007 A1
20070156233 Kapadia et al. Jul 2007 A1
20070161846 Nikolic et al. Jul 2007 A1
20070185571 Kapadia et al. Aug 2007 A1
20070198058 Gelbart et al. Aug 2007 A1
20070213578 Khairkhahan et al. Sep 2007 A1
20070213815 Khairkhahan et al. Sep 2007 A1
20070219460 Goldenberg Sep 2007 A1
20070250160 Rafiee Oct 2007 A1
20070270681 Phillips et al. Nov 2007 A1
20070270688 Gelbart et al. Nov 2007 A1
20070270943 Solem et al. Nov 2007 A1
20080004643 To et al. Jan 2008 A1
20080004697 Lichtenstein et al. Jan 2008 A1
20080033541 Gelbart et al. Feb 2008 A1
20080045778 Lichtenstein et al. Feb 2008 A1
20080071298 Khairkhahan et al. Mar 2008 A1
20080086164 Rowe Apr 2008 A1
20080132915 Buckman et al. Jun 2008 A1
20080133002 Gelbart et al. Jun 2008 A1
20080140188 Rahdert et al. Jun 2008 A1
20080177300 Mas et al. Jul 2008 A1
20080262609 Gross et al. Oct 2008 A1
20080288060 Kaye et al. Nov 2008 A1
20090076597 Dahlgren et al. Mar 2009 A1
20090192527 Messas Jul 2009 A1
20090287304 Dahlgren et al. Nov 2009 A1
20100161047 Cabiri Jun 2010 A1
20110082538 Dahlgren et al. Apr 2011 A1
20110087227 Mazur et al. Apr 2011 A1
20110301618 Lichtenstein Dec 2011 A1
20120083806 Goertzen Apr 2012 A1
20120245604 Tegzes Sep 2012 A1
Foreign Referenced Citations (18)
Number Date Country
9015582 Dec 1990 WO
9510320 Apr 1995 WO
0178625 Oct 2001 WO
03015611 Feb 2003 WO
03077800 Sep 2003 WO
2004012629 Feb 2004 WO
2004047679 Jun 2004 WO
2004084746 Oct 2004 WO
2004100803 Nov 2004 WO
2005046520 May 2005 WO
2005070330 Aug 2005 WO
2005102181 Nov 2005 WO
2006017809 Feb 2006 WO
2006105121 Oct 2006 WO
2006135747 Dec 2006 WO
2006135749 Dec 2006 WO
2007021647 Feb 2007 WO
2007115390 Oct 2007 WO
Non-Patent Literature Citations (65)
Entry
Athanasuleas et al., “Surgical Anterior Ventricular Restoration for Ischemic Cardiomyopathy,” Operative Techniques in Thoracic and Cardiovascular Surgery 7(2):66-75, May 2002.
Buchbinder, Maurice, MD, “Dynamic Mitral Valve Annuloplasty: A Reshapable Ring for Residual and Recurring MR,” from the Foundation for Cardiovascular Medicine, La Jolla, CA. May 24, 2007, 23 pages.
Cardiac Implants, URL=http://nmtmedical.com/products/ci/index.htm, download date May 13, 2006, 1 page.
Cooley, “Ventricular Aneurysms and Akinesis,” Cleveland Clinic Quarterly 45(1):130-132, 1978.
Dahlgren et al., “Medical Device for Constricting Tissue or a Bodily Orifice, For Example a Mitral Valve,” Office Action mailed Dec. 18, 2009, for U.S. Appl. No. 12/120,195, 9 pages.
Dahlgren et al., “Medical Device for Constricting Tissue or a Bodily Orifice, For Example a Mitral Valve,” Amendment filed Apr. 13, 2010, for U.S. Appl. No. 12/120,195, 22 pages.
Dahlgren et al., “Medical Device for Constricting Tissue or a Bodily Orifice, For Example a Mitral Valve,” Office Action mailed Jul. 7, 2010, for U.S. Appl. No. 12/120,195, 14 pages.
Dahlgren et al., “Medical Device for Constricting Tissue or a Bodily Orifice, for Example a Mitral Valve,” Preliminary Amendment filed Oct. 6, 2010 for U.S. Appl. No. 12/899,407, 8 pages.
Dahlgren et al., “Medical Device for Constricting Tissue or a Bodily Orifice, for Example a Mitral Valve,” Office Action mailed Sep. 13, 2012 for U.S. Appl. No. 12/899,407, 10 pages.
Dahlgren et al., “Medical Device, Kit and Method for Constricting Tissue or a Bodily Orifice, For Example a Mitral Valve,” U.S. Appl. No. 61/278,232, filed Oct. 1, 2009, 214 pages.
David et al., “Postinfarction Ventricular Septal Rupture: Repair by Endocardial Patch with Infarct Exclusion,” Journal of Thoracic and Card Surgery 110(5):1315-1322, 1995.
Dor et al., “Late Hemodynamic Results After Left Ventricular Patch Repair Associated with Coronary Grafting in Patients with Postinfarction Akinetic or Dyskinetic Aneurysm of the Left Ventricle,” Journal of Thoracic and Cardiovascular Surgery 110(5):1291-1301, 1995.
Dor et al., “Left Ventricular Aneurysm: A New Surgical Approach,” Thoracic Cardiovascular Surgery 37:11-19, 1989.
Dor, “Left Ventricular Aneurysms: The Endoventricular Circular Patch Plasty,” Seminars in Thoracic and Cardiovascular Surgery 9(2):123-130, Apr. 1997.
Gelbart et al., “Artificial Valve,” Office Action mailed May 7, 2010 for U.S. Appl. No. 11/497,306, 12 pages.
Gelbart et al., “Artificial Valve,” Preliminary Amendment filed Jan. 29, 2010 for U.S. Appl. No. 11/497,306, 22 pages.
Gelbart et al., “Automatic Atherectomy System,” Office Action mailed Mar. 4, 2009 for U.S. Appl. No. 11/436,584, 7 pages.
Gelbart et al., “Method and Device for Closing Holes in Tissue,” Office Action mailed Sep. 4, 2008, for U.S. Appl. No. 11/436,585, 8 pages.
Gelbart et al., “Method and Device for Closing Holes in Tissue,” Amendment filed Sep. 22, 2008, for U.S. Appl. No. 11/436,585, 3 pages.
Gelbart et al., “Method and Device for Closing Holes in Tissue,” Office Action mailed Jan. 2, 2009, for U.S. Appl. No. 11/436,585, 11 pages.
Gelbart et al., “Method and Device for Closing Holes in Tissue,” Amendment filed Jan. 30, 2009, for U.S. Appl. No. 11/436,585, 5 pages.
Gelbart et al., “Method and Device for Closing Holes in Tissue,” Amendment filed Jun. 2, 2009, for U.S. Appl. No. 11/436,585, 7 pages.
Gelbart et al., “Method and Device for Closing Holes in Tissue,” Office Action mailed Jul. 7, 2009, for U.S. Appl. No. 11/436,585, 9 pages.
Gelbart et al., “Method and Device for Closing Holes in Tissue,” Amendment filed Oct. 26, 2009, for U.S. Appl. No. 11/436,585, 13 pages.
Gelbart et al., “Method and Device for Closing Holes in Tissue,” Office Action mailed Feb. 23, 2012 for U.S. Appl. No. 12/777,883, 8 pages.
Gelbart et al., “Method and Device for Closing Holes in Tissue,” Amendment filed May 4, 2012 for U.S. Appl. No. 12/777,883, 12 pages.
Goertzen et al., “Tissue Anchor System,” Amendment filed Apr. 29, 2013, for U.S. Appl. No. 13/247,380, 22 pages.
Goertzen et al., “Tissue Anchor System,” Office Action mailed Jan. 29, 2013, for U.S. Appl. No. 13/247,380, 10 pages.
Goertzen et al., “Tissue Anchor System,” Office Action mailed Aug. 13, 2013, for U.S. Appl. No. 13/247,380, 15 pages.
International Search Report, mailed Jan. 8, 2007, for PCT/CA2006/001123, 5 pages.
International Search Report, mailed Jun. 16, 2011, for PCT/US2010/050945, 5 pages.
International Search Report, mailed Sep. 4, 2009, for PCT/US2009/043612, 7 pages.
Jatene, “Left Ventricular Aneurysmectomy,” Journal of Thoracic and Cardiovascular Surgery 89(3):321-331, 1985.
Konings et al., “Development of an Intravascular Impedance Catheter for Detection of Fatty Lesions in Arteries,” IEEE Transactions on Medical Imaging, 16(4):439-446, 1997.
Lichtenstein, “Closing Openings in Anatomical Tissue,” Office Action mailed May 8, 2013, for U.S. Appl. No. 13/112,695, 12 pages.
Lichtenstein, “Closing Openings in Anatomical Tissue,” Amendment filed Aug. 8, 2013, for U.S. Appl. No. 13/112,695, 23 pages.
Lichtenstein, “Method and Apparatus for Percutaneous Reduction of Anterior-Posterior Diameter of Mitral Valve,” U.S. Appl. No. 10/690,131, filed Oct. 20, 2003, 31 pages.
Lichtenstein, “Method and Apparatus for Percutaneous Reduction of Anterior-Posterior Diameter of Mitral Valve,” Office Action mailed May 15, 2006, for U.S. Appl. No. 10/690,131, 9 pages.
Lichtenstein, “Method and Apparatus for Percutaneous Reduction of Anterior-Posterior Diameter of Mitral Valve,” Office Action mailed Dec. 1, 2008, for U.S. Appl. No. 11/400,260, 10 pages.
Lichtenstein et al, “Method for Anchoring a Mitral Valve,” Amendment filed Aug. 31, 2009, for U.S. Appl. No. 11/475,978, 24 pages.
Lichtenstein et al, “Method for Anchoring a Mitral Valve,” Amendment filed Mar. 26, 2010, for U.S. Appl. No. 11/475,978, 26 pages.
Lichtenstein et al, “Method for Anchoring a Mitral Valve,” Office Action mailed Dec. 29, 2009, for U.S. Appl. No. 11/475,978, 7 pages.
Lichtenstein et al., “Method for Anchoring a Mitral Valve,” Office Action mailed May 1, 2009, for U.S. Appl. No. 11/475,978, 6 pages.
Lichtenstein et al., “System for Improving Diastolic Dysfunction,” Office Action mailed Dec. 24, 2008 for U.S. Appl. No. 11/497,309, 8 pages.
Lichtenstein et al., “System for Improving Diastolic Dysfunction,” Amendment filed Apr. 22, 2009 for U.S. Appl. No. 11/497,309, 23 pages.
Lichtenstein et al., “System for Improving Diastolic Dysfunction,” Office Action mailed Aug. 5, 2009 for U.S. Appl. No. 11/497,309, 10 pages.
Lichtenstein et al., “System for Improving Diastolic Dysfunction,” Amendment filed Oct. 23, 2009 for U.S. Appl. No. 11/497,309, 9 pages.
Lichtenstein et al., “System for Improving Diastolic Dysfunction,” Office Action mailed Jan. 20, 2010 for U.S. Appl. No. 11/497,309, 10 pages.
Lichtenstein et al., “System for Improving Diastolic Dysfunction,” Amendment filed Apr. 7, 2010 for U.S. Appl. No. 11/497,309, 8 pages.
Mack, “New Techniques for Percutaneous Repair of the Mitral Valve,” Heart Failure Review, 11:259-268, 2006.
Mazur et al., “Bone Fixation Device, Tools and Methods,” U.S. Appl. No. 61/138,920, filed Dec. 18, 2008, 88 pages.
Menicanti et al., “The Dor Procedure: What has Changed After Fifteen Years of Clinical Practice?” Journal of Thoracic and Cardiovascular Surgery 124(5):886-890, Nov. 2002.
Otasevic et al., “First-in-Man Implantation of Left Ventricular Partitioning Device in a Patient With Chronic Heart Failure: Twelve-Month Follow-up,” Journal of Cardiac Failure 13(7):517-520, 2007.
Rivera et al., “Ventricular Aneurysms and Akinesis,” Cleveland Clinic Quarterly 45(1):133-135, 1978.
Sharkey et al., “Left Ventricular Apex Occluder. Description of a Ventricular Partitioning Device,” EuroIntervention 2:125-127, 2006.
Stiles, et al., “Simulated Characterization of Atherosclerotic Lesions in the Coronary Arteries by Measurement of Bioimpedance,” IEE Transactions on Biomedical Engineering, 50(7):916-921, 2003.
Tanaka et al., “Artificial SMA Valve for Treatment of Urinary Incontinence: Upgrading of Valve and Introduction of Transcutaneous Transformer,” Bio-Medical Materials and Engineering 9:97-112, 1999.
Tegzes, “Medical Kit for Constricting Tissue or a Bodily Orifice, for Example, a Mitral Valve,” U.S. Appl. No. 61/467,883, filed Mar. 25, 2011, 167 pages.
Timek et al., “Septal-Lateral Annular Cinching (‘SLAC’) Reduces Mitral Annular Size Without Perturbing Normal Annular Dynamics,” Journal of Heart Valve Disease 11(1):2-10, 2002.
Timek et al., “Septal-Lateral Annular Cinching Abolishes Acute Ischemic Mitral Regurgitation,” Journal of Thoracic and Cardiovascular Surgery, 123(5):881-888, 2002.
Torrent-Guasp et al., “Spatial Orientation of the Ventricular Muscle Band and Approach to Partial Ventriculotomy in Heart Failure,” Pathogenesis and Treatment, Ch. 36, pp. 685-693, 2002.
Valvano et al., “Thermal Conductivity and Diffusivity of Biomaterials Measured with Self-Heated Thermistors,” International Journal of Thermodynamics, 6(3):301-311, 1985.
Written Opinion, mailed Jun. 16, 2011, for PCT/US2010/050945, 4 pages.
Written Opinion, mailed Jan. 8, 2007, for PCT/CA2006/001123, 6 pages.
Written Opinion, mailed Sep. 4, 2009, for PCT/US2009/043612, 6 pages.
Related Publications (1)
Number Date Country
20130238089 A1 Sep 2013 US
Divisions (1)
Number Date Country
Parent 11475978 Jun 2006 US
Child 13872870 US